within Pharmacolibrary.Drugs.ATC.C;

model C07CB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 1.0,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Metoprolol and other diuretics (ATC code C07CB02) refers to combination therapies used in the management of hypertension and heart failure, where metoprolol (a selective beta-1 adrenergic blocker) is combined with one or more diuretics. These combinations provide antihypertensive and cardioprotective effects and remain approved for use today in various formulations.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models specifically for the fixed combination product 'metoprolol and other diuretics' (ATC C07CB02). The following parameters are estimated based on typical metoprolol and thiazide diuretic oral co-administration in adults with hypertension.</p><h4>References</h4><ol><li><p>Jonkman, JH, &amp; Upton, RA (1984). Pharmacokinetic drug interactions with theophylline. <i>Clinical pharmacokinetics</i> 9(4) 309–334. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198409040-00002&quot;>10.2165/00003088-198409040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6147220/&quot;>https://pubmed.ncbi.nlm.nih.gov/6147220</a></p></li><li><p>Lancaster, SG, &amp; Sorkin, EM (1988). Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. <i>Drugs</i> 36(3) 256–285. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198836030-00002&quot;>10.2165/00003495-198836030-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2903820/&quot;>https://pubmed.ncbi.nlm.nih.gov/2903820</a></p></li><li><p>Brogden, RN, &amp; Sorkin, EM (1990). Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. <i>Drugs</i> 40(6) 903–949. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199040060-00010&quot;>10.2165/00003495-199040060-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2079001/&quot;>https://pubmed.ncbi.nlm.nih.gov/2079001</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07CB02;
